Abstract
Purpose: Despite many new ASM, the rate of patients with drug-resistant epilepsy (DRE) has not changed. Cenobamate (CNB) is a novel ASM for the treatm......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
